Entries by thibault.affre@gmail.com

,

Laboratoire X.O begins a new stage of its growth with the support of Stanley Capital

04 October 2022, London – Stanley Capital Partners (SCP) has invested in a majority stake in French pharmaceutical group Laboratoire XO (Lab XO). Debt was provided by US lending giant Ares Management. Headquartered in Saint Cloud, France and founded in 2015, Lab XO specialises in mature market authorisations to sell and market drugs across various therapeutic […]

7 October 2022 by
,

New transaction for Laboratoire XO

Paris, October 29, 2021 – Laboratoire X.O has entered into a transaction with Astellas Pharma Inc. for the rights to nicardipine (3 brands) in 4 European countries. This will strengthen our portfolio of 24 brands and our European footprint. Since its creation in 2015, Laboratoire X.O has completed 12 M&A transactions and confirmed its position […]

10 November 2021 by
,

Laboratoire XO celebrates its 5th anniversary

Laboratoire X.O is a French success story. Our objective? To provide patients and healthcare professionals with innovative, qualitative products of real therapeutic interest. The story began in 2015 with the acquisition of 2 brands identified by our Managing Director Karine Pinon. Following her meeting with Gérard Leduc, both agreed on the potential of these brands […]

1 October 2020 by
,

Laboratoire XO launches its brand new mouthwash

As part of the extension of Laboratoire X.O’s range of OTC products, a new range of cosmetic mouthwashes with disruptive flavours has been launched: Prexifresh Mango & Mint. This is a daily treatment whose objective is to reduce the bacterial load with an antiseptic action while combining effectiveness and pleasure. Laboratoire X.O’s aim is to […]

1 June 2020 by

Signature of the laboratore X.O and VPS LIFEPHARMA

It was in the United Arab Emirates, and more precisely in Dubai at the opening of the Arab Health Meeting, that we signed a memorandum of understanding with a leading regional player, VPS LifePharma. VPS Healthcare’s drug manufacturing arm, LIFEPharma, aims to enter the European and US markets, which will be a major step towards […]

28 January 2020 by
,

1 in 2 women suffer from painful periods…

1 femme sur 2 souffre de règles douloureuses… According to a study carried out on a representative sample of patients from the Social Security Health Examination Centres, 49% of non-menopausal women suffer from pain during their periods. Dysmenorrhoea is now recognised as a real pathology. Laboratoire X.O, in its aim to provide care for all, […]

7 November 2018 by